A new herbal formula, KSG-002, suppresses breast cancer growth and metastasis by targeting NF- B-dependent TNF α production in macrophages

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Woo, Sang Mi ^a   Choi, Youn Kyung ^a   Cho, Sung Gook ^a   Park, Sunju ^a   Ko, Seong Gyu ^a  

^a Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGELICA GIGAS EXTRACT; ASTRAGALUS MEMBRANACEUS EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANGELICA; ANGELICA GIGAS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTRAGALUS MEMBRANACEUS; BREAST CANCER; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; COHORT ANALYSIS; CONTROLLED STUDY; IN VIVO STUDY; LUNG METASTASIS; MACROPHAGE; MEDICINAL PLANT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RANDOMIZED CONTROLLED TRIAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; XENOGRAFT;

EID: 84879370683     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/728258     Document Type: Article

References (41)

1. Hanahan D., Coussens L. M., Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012 21 309 322
2. Artacho-Cordon A., Artacho-Cordon F., Rios-Arrabal S., Calvente I., Nunez M. I., Tumor microenvironment and breast cancer progression: a complex scenario. Cancer Biology and Therapy 2012 13 14 24
3. Spano D., Zollo M., Tumor microenvironment: a main actor in the metastasis process. Clinical and Experimental Metastasis 2012 29 381 395
4. Mantovani A., Sica A., Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Current Opinion in Immunology 2010 22 2 231 237 2-s2.0-77950944395 10.1016/j.coi.2010.01.009
5. Ruffell B., Affara N. I., Coussens L. M., Differential macrophage programming in the tumor microenvironment. Trends in Immunology 2012 33 119 126
6. Coffelt S. B., Hughes R., Lewis C. E., Tumor-associated macrophages: effectors of angiogenesis and tumor progression. Biochimica et Biophysica Acta 2009 1796 1 11 18 2-s2.0-68949114117 10.1016/j.bbcan.2009.02.004
7. Solinas G., Marchesi F., Garlanda C., Mantovani A., Allavena P., Inflammation-mediated promotion of invasion and metastasis. Cancer and Metastasis Reviews 2010 29 2 243 248 2-s2.0-77954565039 10.1007/s10555-010-9227- 2
8. Hsiao W. L. W., Liu L., The role of traditional Chinese herbal medicines in cancer therapy from TCM theory to mechanistic insights. Planta Medica 2010 76 11 1118 1131 2-s2.0-77955058763 10.1055/s-0030-1250186
9. Burstein H. J., Polyak K., Wong J. S., Lester S. C., Kaelin C. M., Ductal carcinoma in situ of the breast. The New England Journal of Medicine 2004 350 14 1430 1441 2-s2.0-1842483408 10.1056/NEJMra031301
10. Yang H., Bocchetta M., Kroczynska B., Elmishad A. G., Chen Y., Liu Z., Bubici C., Mossman B. T., Pass H. I., Testa J. R., Franzoso G., Carbone M., TNF- α inhibits asbestos-induced cytotoxicity via a NF- B-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proceedings of the National Academy of Sciences of the United States of America 2006 103 27 10397 10402 2-s2.0-33745892099 10.1073/pnas.0604008103
11. Zhang J., Stirling B., Temmerman S. T., Ma C. A., Fuss I. J., Derry J. M. J., Jain A., Impaired regulation of NF- B and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice. The Journal of Clinical Investigation 2006 116 11 3042 3049 2-s2.0-33750598021 10.1172/JCI28746
12. Mocellin S., Rossi C. R., Pilati P., Nitti D., Tumor necrosis factor, cancer and anticancer therapy. Cytokine and Growth Factor Reviews 2005 16 1 35 53 2-s2.0-14044261093 10.1016/j.cytogfr.2004.11.001
13. Jedinak A., Dudhgaonkar S., Sliva D., Activated macrophages induce metastatic behavior of colon cancer cells. Immunobiology 2010 215 3 242 249 2-s2.0-77949262399 10.1016/j.imbio.2009.03.004
14. Oguma K., Oshima H., Aoki M., Uchio R., Naka K., Nakamura S., Hirao A., Saya H., Taketo M. M., Oshima M., Activated macrophages promote Wnt signalling through tumour necrosis factor- α in gastric tumour cells. EMBO Journal 2008 27 12 1671 1681 2-s2.0-47049116663 10.1038/emboj.2008.105
15. Karin M., Nuclear factor- B in cancer development and progression. Nature 2006 441 7092 431 436 2-s2.0-33745298519 10.1038/nature04870
16. Inoue J., Gohda J., Akiyama T., Semba K., NF- B activation in development and progression of cancer. Cancer Science 2007 98 3 268 274 2-s2.0-33846685017 10.1111/j.1349-7006.2007.00389.x
17. Shih V. F., Tsui R., Caldwell A., Hoffmann A., A single NF B system for both canonical and non-canonical signaling. Cell Research 2011 21 1 86 102 2-s2.0-78650907445 10.1038/cr.2010.161
18. Rosenblum H., Amital H., Anti-TNF therapy: safety aspects of taking the risk. Autoimmunity Reviews 2011 10 9 563 568 2-s2.0-79957927386 10.1016/j.autrev.2011.04.010
19. Zidi I., Mestiri S., Bartegi A., Amor N. B., TNF- α and its inhibitors in cancer. Medical Oncology 2010 27 2 185 198 2-s2.0-77956898009 10.1007/s12032-009-9190-3
20. Wang S., Penchala S., Prabhu S., Wang J., Huang Y., Molecular basis of traditional chinese medicine in cancer chemoprevention. Current Drug Discovery Technologies 2010 7 1 67 75 2-s2.0-77951717597 10.2174/157016310791162794
21. Chiu P. H., Hsieh H. Y., Wang S. C., Prescriptions of traditional Chinese medicine are specific to cancer types and adjustable to temperature changes. PLoS One 2012 7 e31648
22. Lin Y. H., Chiu J. H., Use of Chinese medicine by women with breast cancer: a nationwide cross-sectional study in Taiwan. Complementary Therapies in Medicine 2011 19 3 137 143 2-s2.0-79957968302 10.1016/j.ctim.2011.04.001
23. Shin J. W., Son J. Y., Kang J. K., Han S. H., Cho C. K., Son C. G., Trichosanthes kirilowii tuber extract induces G2/M phase arrest via inhibition of tubulin polymerization in HepG2 cells. Journal of Ethnopharmacology 2008 115 2 209 216 2-s2.0-37249005198 10.1016/j.jep.2007.09.030
24. Kongtun S., Jiratchariyakul W., Kummalue T., Tan-ariya P., Kunnachak S., Frahm A. W., Cytotoxic properties of root extract and fruit juice of Trichosanthes cucumerina. Planta Medica 2009 75 8 839 842 2-s2.0-69049120250 10.1055/s-0029-1185455
25. Heo B. G., Chon S. U., Park Y. J., Bae J. H., Park S. M., Park Y. S., Jang H. G., Gorinstein S., Antiproliferative activity of Korean wild vegetables on different human tumor cell lines. Plant Foods for Human Nutrition 2009 64 4 257 263 2-s2.0-71449105635 10.1007/s11130-009-0138-8
26. Li L. K., Kuang W. J., Huang Y. F., Xie H. H., Chen G., Zhou Q. C., Wang B. R., Wan L. H., Anti-tumor effects of Astragalus on hepatocellular carcinoma in vivo. Indian Journal of Pharmacology 2012 44 78 81
27. Cho W. C. S., Leung K. N., In vitro and in vivo anti-tumor effects of Astragalus membranaceus. Cancer Letters 2007 252 1 43 54 2-s2.0-34248369813 10.1016/j.canlet.2006.12.001
28. Cheng X. D., Hou C. H., Zhang X. J., Xie H. Y., Zhou W. Y., Yang L., Zhang S. B., Qian R. L., Effects of Huangqi (Hex) on inducing cell differentiation and cell death in K562 and HEL cells. Acta Biochimica et Biophysica Sinica 2004 36 3 211 217 2-s2.0-2442619242
29. Cui R., He J., Wang B., Zhang F., Chen G., Yin S., Shen H., Suppressive effect of Astragalus membranaceus Bunge on chemical hepatocarcinogenesis in rats. Cancer Chemotherapy and Pharmacology 2003 51 1 75 80 2-s2.0-0037222738 10.1007/s00280-002-0532-5
30. Du Q. C., Yang K. Z., Sun X. F., Efficacy of auxiliary therapy with Danggui Buxue Decoction No.1 in treating patients of non-small cell lung cancer at peri-operational stage. Chinese Journal of Integrative Medicine 2009 15 3 184 188 2-s2.0-67650466974 10.1007/s11655-009-0184-y
31. Laoui D., Movahedi K., van Overmeire E., van den Bossche J., Schouppe E., Mommer C., Nikolaou A., Morias Y., de Baetselier P., van Ginderachter J. A., Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions. International Journal of Developmental Biology 2011 55 7-9 861 867 2-s2.0-82555181278 10.1387/ijdb.113371dl
32. Mukhtar R. A., Moore A. P., Nseyo O., Baehner F. L., Au A., Moore D. H., Twomey P., Campbell M. J., Esserman L. J., Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity. Breast Cancer Research and Treatment 2011 130 2 635 644 2-s2.0-82955163125 10.1007/s10549-011-1646-4
33. Medrek C., Ponten F., Jirstrom K., Leandersson K., The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer 2012 12, article 306
34. Foulkes W. D., Smith I. E., Reis-Filho J. S., Triple-negative breast cancer. The New England Journal of Medicine 2010 363 20 1938 1948 2-s2.0-78149483057 10.1056/NEJMra1001389
35. DeSantis C., Siegel R., Bandi P., Jemal A., Breast cancer statistics. CA: A Cancer Journal for Clinicians 2011 61 409 418
36. Sotiriou C., Pusztai L., Gene-expression signatures in breast cancer. The New England Journal of Medicine 2009 360 8 752 800 2-s2.0-60849097255 10.1056/NEJMra0801289
37. Kang S. P., Martel M., Harris L. N., Triple negative breast cancer: current understanding of biology and treatment options. Current Opinion in Obstetrics and Gynecology 2008 20 1 40 46 2-s2.0-38149014061 10.1097/GCO.0b013e3282f40de9
38. Metro G., Fabi A., New target therapies for brain metastases from breast cancer. Current Cancer Drug Targets 2012 12 210 217
39. Yagata H., Kajiura Y., Yamauchi H., Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy. Breast Cancer 2011 18 3 165 173 2-s2.0-81855163378 10.1007/s12282-011-0254-9
40. Wu H., Xu J. B., He Y. L., Peng J. J., Zhang X. H., Chen C. Q., Li W., Cai S. R., Tumor-associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer. Journal of Surgical Oncology 2012 106 462 468
41. Chen W., Ma T., Shen X. N., Xia X. F., Xu G. D., Bai X. L., Liang T. B., Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway. Liver Transplantation 2012 18 S160 S160